Bharat Biotech bets on vaccines to fight drug resistance, eyes post-Covid growth

Hyderabad-based Bharat Biotech is developing novel vaccines to combat antimicrobial resistance (AMR), a significant global health threat. The company aims to administer these vaccines pre-surgery to prevent hospital-acquired infections, addressing a growing need due to rising drug resistance.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ulNcXrk
via IFTTT